ad image

Probiotics

1 / 1
Applying Synthetic Biology to Elevate Probiotics
Probiotics

Applying Synthetic Biology to Elevate Probiotics

Unlocked Labs

PAO-04-22-R250-10Apr 07, 2022
Bringing Novel Delivery Technologies to the North American Market
Drug Delivery

Bringing Novel Delivery Technologies to the North American Market

Walter Bertin

Labomar

PAP-Q4-19-CL-020Dec 06, 2019
ResearchandMarkets
Market Prediction

Dissection of the Global $73+ Billion Probiotics Market by 2024

ResearchandMarkets

PR-M05-19-NI-044May 15, 2019
HUM Nutrition
Probiotics

HUM Nutrition Introduces Pre and Probiotic Supplement Formulated for Acne-prone (Non-cystic) and Dry Skin After Concluding Consumer Study

HUM Nutrition

PR-M04-19-NI-027Apr 08, 2019
Seqens
Probiotics

Megabiotic™-44, a Pre and Postbiotics Complex, from Lactobacillus Bulgaricus GLB44, Microorganism Able to Enhance Pore Refinement

Seqens

PR-M04-19-NI-018Apr 01, 2019
Seed®
Probiotics

Scientists Clarify What Probiotics Are

Seed®

PR-M03-19-NI-048Mar 18, 2019
ReportLinker
Probiotics

The Probiotics Market is Estimated to be Valued at 45.64 Billion in 2017, and Projected to Grow at a CAGR of 7.0%, to Reach USD 64.02 Billion by 2022

ReportLinker

PR-M01-19-NI-068Jan 23, 2019
Hard-Shell Capsule Solutions for Sensitive Compounds: A Focus on Probiotics
Probiotics

Hard-Shell Capsule Solutions for Sensitive Compounds: A Focus on Probiotics

Eli Elias

CapsCanada

PAO-M12-18-CL-002Dec 06, 2018
Probiotic Ingredients Market Worth Over $3 Billion by 2024: Global Market Insights, Inc.
Probiotics

Probiotic Ingredients Market Worth Over $3 Billion by 2024: Global Market Insights, Inc.

PR-M11-18-NI-103Nov 29, 2018
Visiongain
Probiotics

Visiongain Report Researches Growth Opportunities Within the $59bn Global Probiotics Market

Visiongain

PR-M11-18-NI-033Nov 09, 2018
Bacteria in the Stomach Found to Play a Role in Multiple Sclerosis
Drug Development

Bacteria in the Stomach Found to Play a Role in Multiple Sclerosis

Emilie Branch

Pharma's Almanac

PAO-M05-18-NI-016May 24, 2018
Kaneka
Investment

Kaneka has invested in AB-Biotics SA, a Spanish biotech company and concluded a license agreement for production and sales of its probiotics products

Kaneka

PR-M05-18-NI-067May 17, 2018
Partnership to Develop Clostridial-Based Medicines Moves Forward
Drug Development

Partnership to Develop Clostridial-Based Medicines Moves Forward

Marc Technow

Nice Insight

PR-M03-18-NI-104Mar 30, 2018
J&J Involved in Probiotics Development Program
Probiotics

J&J Involved in Probiotics Development Program

Emilie Branch

Pharma's Almanac

PR-M03-18-NI-100Mar 29, 2018
1 / 1